Bennett A M, Williams G M
Department of Experimental Pathology, New York Medical College, Valhalla 10595.
Biochem Pharmacol. 1993 Dec 14;46(12):2219-27. doi: 10.1016/0006-2952(93)90612-z.
The non-genotoxic hepatocarcinogen and peroxisome proliferating agent, ciprofibrate, is a liver mitogen both in vivo and in cultured adult rat hepatocytes, but the mechanisms of its mitogenicity have not been elucidated. We previously observed that ciprofibrate rapidly increased hepatocyte free intracellular Ca2+ concentration ([Ca2+]i), suggesting that this effect may play a role in the initiation of DNA synthesis. In the present study, we have identified a relationship between Ca2+ and the stimulation of hepatocyte DNA synthesis by ciprofibrate. Exposure of cultured adult rat hepatocytes to ciprofibrate (200 microM) for 48 hr increased DNA synthesis by approximately 2-fold, and this response was attenuated in a Ca(2+)-deficient medium and by the Ca2+ channel blockers nicardipine and verapamil. To examine the relationship between the stimulation of hepatocyte DNA synthesis and increases in [Ca2+]i by ciprofibrate, the intracellular Ca2+ chelator 5,5'-dimethyl-1,2-bis(2-aminophenoxyethane)-N,N,N',N'-tetraacetic acid (dimethyl-BAPTA) was employed. Pretreatment of hepatocytes with dimethyl-BAPTA blocked ciprofibrate-induced [Ca2+]i increase, but did not block ciprofibrate-induced hepatocyte DNA synthesis. Dimethyl-BAPTA was only effective in reducing ciprofibrate-induced DNA synthesis when present during the latter 24 hr of a 48-hr culture period. These data suggest that the early mobilization of hepatocyte [Ca2+]i by ciprofibrate does not play an initiating role in the induction of hepatocyte DNA synthesis but rather may operate as a permissive factor for the entry of ciprofibrate-treated adult rat hepatocytes into S-phase.
非基因毒性肝癌致癌物及过氧化物酶体增殖剂环丙贝特,在体内及培养的成年大鼠肝细胞中均为肝脏有丝分裂原,但其促有丝分裂的机制尚未阐明。我们之前观察到环丙贝特能迅速增加肝细胞内游离钙离子浓度([Ca2+]i),提示该效应可能在DNA合成起始过程中发挥作用。在本研究中,我们确定了Ca2+与环丙贝特刺激肝细胞DNA合成之间的关系。将培养的成年大鼠肝细胞暴露于环丙贝特(200 microM)48小时,可使DNA合成增加约2倍,而在缺钙培养基中以及使用钙离子通道阻滞剂尼卡地平和维拉帕米时,该反应会减弱。为了研究环丙贝特刺激肝细胞DNA合成与[Ca2+]i增加之间的关系,使用了细胞内钙离子螯合剂5,5'-二甲基-1,2-双(2-氨基苯氧基乙烷)-N,N,N',N'-四乙酸(二甲基- BAPTA)。用二甲基- BAPTA预处理肝细胞可阻断环丙贝特诱导的[Ca2+]i增加,但不阻断环丙贝特诱导的肝细胞DNA合成。仅在48小时培养期的后24小时存在时,二甲基- BAPTA才有效降低环丙贝特诱导的DNA合成。这些数据表明,环丙贝特早期动员肝细胞[Ca2+]i在诱导肝细胞DNA合成中不发挥起始作用,而可能作为环丙贝特处理的成年大鼠肝细胞进入S期的允许因子发挥作用。